Psychotropics and Pregnancy: Timing Matters

Moderator(s)

• 

  Elizabeth Suarez, PhD

  Instructor
  Rutgers Institute for Health
  Boston, United States
• 

  Anick Bérard, PhD, FCAHS, FISPE (she/her/hers)

  Professor
  Université de Montréal
  Montreal, Canada

Presentations:

• 8:00 AM – 8:15 AM CEST

  Initiating Antidepressant Treatment in Pregnancy: Timing, Intensity, and Influential Maternal and Familial Factors
  

  Presenting Author: Alexis Carson, MPH – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
• 8:15 AM – 8:30 AM CEST

  Timing and Duration of ADHD Medication Use in Pregnancy and Risk of Preterm Birth
  

  Presenting Author: Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

  Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

  Co-Author: Hein Stigum – Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.

  Co-Author: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

  Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

  Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

  Co-Author: Jennifer Hutcheon – Division of Maternal Fetal Medicine, The University of British Columbia, Vancouver, Canada.

  Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health
• 8:30 AM – 8:45 AM CEST

  Z-drug use in the first trimester and risk of congenital malformations in the U.S.
  

  Presenting Author: Kelly Fung, MS – Brigham and Women's Hospital and Harvard Medical School

  Co-Author: Loreen Straub, MD MS (she/her/hers) – Brigham and Women's Hospital/Harvard Medical School

  Co-Author: Brian T. Bateman, MD, MSc – Stanford University

  Co-Author: Ayesha C. Sujan, PhD (she/her/hers) – Stanford University

  Co-Author: Gregory Brill – Brigham and Women's Hospital

  Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health

  Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
• 8:45 AM – 9:00 AM CEST

  Emulating a Target Trial to Estimate the Causal Effect of Antiseizure Medication on Birthweight
  

  Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

  Co-Author: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

  Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
• 9:00 AM – 9:15 AM CEST

  Assessment of non-cardiac congenital malformations and in utero exposure to modafinil/armodafinil in the Sentinel Distributed Database
  

  Presenting Author: Catherine Callahan, PhD, MA (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration

  Co-Author: Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

  Co-Author: Kimberly Barrett – Department of Population Medicine, Harvard Pilgrim Health Care Institute

  Co-Author: Derek Campbell – Department of Population Medicine, Harvard Pilgrim Health Care Institute

  Co-Author: Kira Leishear, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration

  Co-Author: Carrie Ceresa – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration

  Co-Author: Miriam Dinatale – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration
• 9:15 AM – 9:30 AM CEST

  Psychiatric outcomes and their progression across different diagnoses in children and adolescents following prenatal exposure to antidepressants
  

  Presenting Author: Anastasia Giorcelli, MS in Biostatistics (she/her/hers) – Oslo Centre for Biostatistics and Epidemiology - University of Oslo

  Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Lene Maria Sundbakk, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  Co-Author: Sina Rostami – Norwegian Institute of Public Health

  Co-Author: Shuvasa Thapa, MD, PhD – University Of Oslo

  Co-Author: Anna Cantarutti, PhD – University of Milano-Bicocca

  Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway